Transforming Care for Early Stage T1D with Targeted Clinical Strategies

Monday, July 21, 2025

12:00 PM – 1:00 PM ET

Please note this virtually live meeting is at: 12:00 PM Eastern; 11:00 AM Central; 10:00 AM Mountain; 9:00 AM Pacific

FACULTY

Ananta Addala, DO, MPH
Assistant Professor
Department of Pediatrics
Division of Endocrinology & Diabetes
Lucile Packard Children’s Hospital
Stanford University
Laura Jacobsen, MD
Assistant Professor
Associate Fellowship Program Director
Pediatric Endocrinology
University of Florida
Gainesville, FL

PROGRAM DESCRIPTION

This virtual symposium will overview the importance of screening and early detection for type 1 diabetes (T1D), as well as considerations for follow-up, monitoring, and appropriate staging post-T1D screening. In addition, the symposium will also cover therapeutic advances that delay disease progression in individuals with early-stage T1D. Through conversations between expert faculty, high impact animations, and patient cases, this activity will provide valuable insights to pediatric endocrinologists and other clinicians that see T1D patients to improve the early detection and treatment of early-stage T1D.

 TARGET AUDIENCE

This activity is designed to meet the educational needs of Pediatric and Adult Endocrinologists, Pediatricians, Primary Care Providers, and Endocrine Nurses.

LEARNING OBJECTIVES

  • Incorporate evidence-based strategies for presymptomatic T1D screening into routine clinical practice to improve early detection
  • Interpret T1D screening results and effectively communicate next steps to support patient education and inform treatment decisions.
  • Identify appropriate patients who would benefit from treatment with disease-modifying therapies for delaying T1D progression based on clinical evidence
  • Implement protocols to support safe and efficient administration of disease-modifying therapies for T1D according to guidance and patient-specific factors.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this virtually live activity for a maximum of 1.0 ANCC contact hour.

COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 CPEU.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

 

Pin It on Pinterest

Directory
Scroll to Top

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers